Frigeni, Marco http://orcid.org/0000-0003-2493-7749
Besson, Caroline
Visco, Carlo http://orcid.org/0000-0003-2863-0883
Fontaine, Helene
Goldaniga, Maria
Visentini, Marcella
Pulsoni, Alessandro
Torres, Harrys A.
Peveling-Oberhag, Jan
Rossotti, Roberto
Zaja, Francesco
Rigacci, Luigi
Merli, Michele http://orcid.org/0000-0002-0905-5927
Dorival, Céline
Alric, Camille
Piazza, Francesco
Gentile, Massimo http://orcid.org/0000-0002-5256-0726
Ferrari, Angela
Pirisi, Mario
Nassi, Luca
Rattotti, Sara
Frustaci, Annamaria
Milella, Michele
Cencini, Emanuele
Defrancesco, Irene
Ferretti, Virginia Valeria
Bruno, Raffaele
Hermine, Olivier
Arcaini, Luca http://orcid.org/0000-0002-9504-991X
Article History
Received: 12 August 2019
Revised: 16 November 2019
Accepted: 5 December 2019
First Online: 13 December 2019
Compliance with ethical standards
:
: LA received advisory honoraria from Bayer, Celgene, Gilead, Roche, Sandoz, Verastem and research support from Gilead. HAT is or has been the principal investigator for research grants from Gilead Sciences, Merck & Co., Inc., and Vertex Pharmaceuticals, with all funds paid to MD Anderson. HAT also is or has been a paid scientific advisor for Gilead Sciences, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Vertex Pharmaceuticals, Genentech, Novartis, Astellas Pharma, Pfizer Inc., and Theravance Biopharma, Inc.; the terms of these arrangements are being managed by MD Anderson in accordance with its conflict of interest policies. AP received advisory honoraria from Roche, Merck, Pfyzer, Sandoz, Takeda.